- Lobbying
- Lobbying by Novartis Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Tom Scully | Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB. |
Colin Roskey | Health Policy Advisor and Counsel, Senate Finance Committee |
Mark Rayder | LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo. |
Marilyn Yager | Dep. Ass't to the Pres., White House Office of Public Liason |
Y. Brian Lee | Legislative Intern, Rep. Doug Lamborn. |
Jennifer Butler | n/a |
Peter Kazon | n/a |
Rudy Missmar | n/a |
Robert J. Dole | n/a |
Stephanie Curtis | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
U.S. House of Representatives
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medicare
Lobbying Issues
Agencies Lobbied
Veterans Affairs - Dept of (VA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Medical
Medicare
Q1 Report
Registration
Issue(s) they said they’d lobby about: Issues related to coverage and reimbursement of pharmaceuticals..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate